 |
Ash Access Technology has developed novel catheters and an antimicrobial solution to prevent infections in hospitals and dialysis care centers. |
 |
Athersys is developing novel therapeutic drugs and stem cell therapies; their first product is projected to be an anti-obesity drug.
|
 |
Bacchus Vascular focuses on the treatment of occlusive vascular disease with new devices for Interventional Radiologists, Cardiologists, and Vascular Surgeons.
|
 |
CABG Medical manufactures the Holly Graft system for coronary artery bypass grafting, which allows surgeons to bypass coronary occlusions without "harvesting” veins or arteries from the patient.
|
|
CryoCor has engineered a system to freeze and ablate the tissues in the pulmonary veins that cause atrial arrhythmia in the heart.
|
 |
LPL Technologies develops diagnostic blood tests for gynecological cancers.
|
 |
Onset Medical Corporation produces surgical catheters that expand gently after insertion, allowing access to body cavities with decreased trauma.
|
 |
PrognostiX is developing diagnostic tests for inflammatory diseases, including atherosclerosis and asthma.
|
 |
Setagon produces nanoporous metal coatings on medical devices for drug delivery.
|
 |
TissueLink has developed instruments to seal tissue fluids as a surgeon works, vastly decreasing blood loss and providing a virtually dry surgical field.
|
 |
Triage Medical has developed a line of novel orthopedic screws (“Bone-Lok”) that allow surgeons to compress and align bone fragments, even fragile osteoporotic bones, with minimal bone damage.
|
 |
Vertelink is developing systems to allow surgeons to stabilize the spine through minimally invasive, tissue-sparing procedures. Vertelink was acquired by Medtronic in December 2003.
|
 |
Xoft is developing microminiature x-ray tubes and catheter delivery systems, initially utilized to replace lengthy post-lumpectomy radiation treatment in breast cancer.
|
